Clinical Trial

Decision Counseling and Follow-up for Shield+ Patients

Study acronym: DCaF
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
Prospective, observational, minimal-risk study evaluating decision-making, decisional conflict, intention to undergo complete diagnostic evaluation (CDE), and colonoscopy completion after a positive Shield TM blood-based colorectal cancer screening test result.
Trial Details
NCT Number NCT07620535
Lead Sponsor Guardant Health, Inc.
Collaborators: Thomas Jefferson University
Conditions Colo-rectal Cancer
Enrollment 350 participants
Start Date 2026-06
Primary Completion 2027-12 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2026-06-02